These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14656874)

  • 21. Bcl-XL down-regulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivo.
    Coluccia AM; Perego S; Cleris L; Gunby RH; Passoni L; Marchesi E; Formelli F; Gambacorti-Passerini C
    Blood; 2004 Apr; 103(7):2787-94. PubMed ID: 14656879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human umbilical cord blood-derived stromal cells: a new resource for the proliferation and apoptosis of myeloma cells.
    Gao L; Zhang C; Zhang X; Gao L; Hao L; Chen XH
    Hematology; 2014 Apr; 19(3):148-57. PubMed ID: 23896383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of lymphoid apoptosis by Bcl-2 and Bcl-XL.
    Nuñez G; Merino R; Simonian PL; Grillot DA
    Adv Exp Med Biol; 1996; 406():75-82. PubMed ID: 8910673
    [No Abstract]   [Full Text] [Related]  

  • 24. Lymphoproliferative syndrome associated with c-myc expression driven by a class I gene promoter in transgenic mice.
    Morello D; Lavenu A; Bandeira A; Portnoi D; Gaillard J; Babinet C
    Oncogene Res; 1989; 4(2):111-25. PubMed ID: 2654814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma.
    Zhao WL; Daneshpouy ME; Mounier N; Brière J; Leboeuf C; Plassa LF; Turpin E; Cayuela JM; Ameisen JC; Gisselbrecht C; Janin A
    Blood; 2004 Jan; 103(2):695-7. PubMed ID: 12969962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria.
    González-García M; Pérez-Ballestero R; Ding L; Duan L; Boise LH; Thompson CB; Núñez G
    Development; 1994 Oct; 120(10):3033-42. PubMed ID: 7607090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M; Busch G; Beneke R; Gulbins E; Lang F; Ma A; Korsmeyer S; Möröy T
    Oncogene; 1995 Nov; 11(10):2165-74. PubMed ID: 7478538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
    Jiang X; Tsang YH; Yu Q
    Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
    de La Coste A; Mignon A; Fabre M; Gilbert E; Porteu A; Van Dyke T; Kahn A; Perret C
    Cancer Res; 1999 Oct; 59(19):5017-22. PubMed ID: 10519417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs.
    Lei XY; Zhong M; Feng LF; Zhu BY; Tang SS; Liao DF
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):450-6. PubMed ID: 17439414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.
    Vanasse GJ; Winn RK; Rodov S; Zieske AW; Li JT; Tupper JC; Tang J; Raines EW; Peters MA; Yeung KY; Harlan JM
    Mol Cancer Res; 2004 Nov; 2(11):620-31. PubMed ID: 15561778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
    Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
    Yan Y; Park SS; Janz S; Eckhardt LA
    Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D; Thomas-Tikhonenko A
    Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6-mediated up-regulation of bcl-xL.
    Schwarze MM; Hawley RG
    Cancer Res; 1995 Jun; 55(11):2262-5. PubMed ID: 7757973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-6 rescues the hyporesponsiveness of c-Rel deficient B cells independent of Bcl-xL, Mcl-1, and Bcl-2.
    Tumang JR; Hsia CY; Tian W; Bromberg JF; Liou HC
    Cell Immunol; 2002; 217(1-2):47-57. PubMed ID: 12426000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
    Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
    J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members.
    Hogg SJ; Newbold A; Vervoort SJ; Cluse LA; Martin BP; Gregory GP; Lefebure M; Vidacs E; Tothill RW; Bradner JE; Shortt J; Johnstone RW
    Mol Cancer Ther; 2016 Sep; 15(9):2030-41. PubMed ID: 27406984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.
    Hartmann K; Artuc M; Baldus SE; Zirbes TK; Hermes B; Thiele J; Mekori YA; Henz BM
    Am J Pathol; 2003 Sep; 163(3):819-26. PubMed ID: 12937123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
    Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
    Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.